Prevatt Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Prevatt Capital's CME Position: Q2 2026 in Review
Prevatt Capital increased its CME Group (CME) stake by 32% in Q2 2026, buying an estimated $14.4M and bringing the position to 214,000 shares worth $47.3M. The position accounts for 10.25% of the portfolio, ranked #3.
Prevatt Capital first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $47.8M in Q1 2026. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Prevatt Capital held 214,000 shares of CME Group worth $47.3M as of Q2 2026.
- Prevatt Capital bought 52,000 CME Group shares in Q2 2026, an estimated $14.4M.
- CME Group made up 10.25% of Prevatt Capital's portfolio in Q2 2026, its #3 holding.
- Prevatt Capital first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
- Prevatt Capital's CME Group position peaked at $47.8M in Q1 2026.
- 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Prevatt Capital's 13F filing for Q2 2026, filed 14 Aug 2026.